AMPICILLIN FOR INJECTION, USP
FRESENIUS KABI CANADA LTD
Quick answers
Is there a shortage of AMPICILLIN FOR INJECTION, USP in Canada?
No. There is no current shortage of AMPICILLIN FOR INJECTION, USP 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AMPICILLIN SODIUM FOR INJECTION, USP
TEVA CANADA LIMITED
PENBRITIN INJ 250MG
AYERST LABORATORIES
AMPICIN FOR INJECTION 250MG
BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
STERILE AMPICILLIN SODIUM 250MG USP
BIONICHE PHARMA (CANADA) LTD
AMPICILLIN SODIUM FOR INJECTION BP
AURO PHARMA INC
Other Products
AMPICIN INJ 1GM
BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
DIN
02227029
Strength
250MG
Dosage Form
Powder For Solution
Route
Intramuscular Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from FRESENIUS KABI CANADA LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
900MG · DIN 02395150
20MG · DIN 02538644
50MG · DIN 02403536
50MG · DIN 02236926
DIN 02497697
3MG · DIN 02457482
3MG · DIN 02457474
3MG · DIN 02267659
50MG · DIN 02245248
2G · DIN 02226995
1G · DIN 02227002
500MG · DIN 02227010